SEARCH RESULTS FOR: "Tag: HALO"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
2018(3)
2017(4)
2015(11)
2014(1)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(4)
Analyst Upgrades(1)
Buzz Stocks(2)
By the Numbers(1)
Expectational Analysis(1)
General(4)
Intraday Option Activity(1)
Opening View(1)
Quantitative Analysis(1)
Stock Market News(1)
Stocks On the Move(2)
The Week Ahead(1)

11/7/2019 12:56 PM
Halozyme Therapeutics, Inc. (NASDAQ:HALO) is trading 1.2% lower today at $16.70, taking a breather after a 10.5% gap higher on Tuesday following corporate restructuring news. Despite today's pullback,...
5/11/2018 10:03 AM
Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock is down 9.3% to trade at $18.12 this morning, after the biotech company reported first-quarter revenue short of analysts' forecasts, as well as a weaker...
2/21/2018 10:30 AM
Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock is up 3.1% to trade at $19.11 this morning, after Canaccord Genuity upped its price target on the oncology specialist to $21 from $19. The analyst in co...
1/17/2018 9:27 AM
Shares of oncology biotech Halozyme Therapeutics, Inc. (NASDAQ:HALO) are trading 12.2% lower before the open, after Deutsche Bank analyst Andrew Peters cut his price target by $2 to $19. Peters label...
11/8/2017 9:34 AM
Analysts are weighing in on Grand Theft Auto parent Take-Two Interactive Software, Inc. (NASDAQ:TTWO), biotech Halozyme Therapeutics, Inc. (NASDAQ:HALO), and photonics stock Coherent, Inc. (NASDAQ:C...
Partner Center